This early upregulation of protooncogenic pathways is driven in part by the activity of the insulin receptor, which is highly upregulated in rat diabetes-associated CCTs compared to the surrounding tubular apparatus [34,35]. This evidence concerns the gene INSR and diabetes mellitus.